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Hypoxia-induced modulation of endothelial cell properties: Regulation
of barrier function and expression of interleukin-6. The endothelial cell
response to hypoxia involves a range of adaptive mechanisms that reflect
an active response of the cell's biosynthetic and metabolic apparatus.
Hypoxia-mediated suppression of endothelial barrier function, resulting in
increased vascular leakage, is likely to contribute to pulmonary and
cerebral edema associated with high altitude and is closely associated with
a fall in intracellular cyclic AMP levels. Buttressing of this second
messenger pathway in the endothelium using membrane permeant cyclic
AMP analogs prevents increased vascular leakage due to hypoxia. Appli-
cation of this principle to organ preservation has shown that supplemen-
tation with cyclic AMP analogs or inhibition of endogenous cAMP
metabolism enables extension of the time a harvested organ can remain
extracorporeally, after which transplantation is successful. The underlying
mechanism through which cyclic AMP exerts its effects appears to be
maintenance of vascular homeostasis in the graft. A distinct adaptive
mechanism triggered in the endothelium by hypoxia is expression of the
cytokine interleukin-6 (IL-6) by a novel mechanism involving transcription
driven by the nuclear factor IL-6 (NF-IL-6) DNA binding site in the
promoter. IL-b may exert protective effects on vascular function, thereby
limiting vascular injury by a different mechanism than those recruited by
elevated cAMP levels. These studies provide insights into two indepen-
dent mechanisms through which endothelium responds to oxygen depri-
vation, and suggest possible new approaches to attentuate vascular injury
associated with ischemia.
As cells form the luminal vascular surface, endothelial cells are
rapidly and completely immersed in the vascular microenviron-
ment and are thereby subject to any changes therein. A common
denominator of many vascular disorders is diminished levels of
blood oxygen, often accompanied by decreased blood flow with
accumulation of metabolic waste products and depletion of
nutrients. To approach the mechanisms of cellular dysfunction
associated with such ischemia, we have focused on the cellular
effects of hypoxia/hypoxemia. In contrast to certain cells which are
susceptible to loss of viability with severe hypoxia, such as neurons
and cardiac myocytes, the endothelium maintains its integrity for
extended times with oxygen tensions of 8 to 12 torr in the medium
bathing the cell [1, 2]. After 48 hours of hypoxia, endothelial levels
of ATP remain at about 70% of that in normoxic control cultures,
and protein synthesis is maintained, also at close to 70 to 80% the
level observed in normoxia [1, 3]. Following cessation of hypoxia,
each of these parameters returns to the normoxic baseline, and
the cultures remain viable. Thus, hypoxia induces a reversible
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modulation of endothelial functions. We hypothesize that one
reason for the hardiness of endothelial cells subject to hypoxia is
the effectiveness with which they switch to anaerobic metabolism.
Not only is there rapid induction of several glycolytic enzymes, but
the insulin-independent glucose transporter (GLUT 1) is up-
regulated, allowing for the observed increased and efficient cellu-
lar uptake of glucose from the medium [3—5].
The maintenance of general cellular metabolic and biosynthetic
properties masks a more subtle perturbation of many endothelial
properties, such as those regulating vascular barrier function and
the expression of cytokines influencing immune/inflammatory
responses. This review will focus on mechanisms through which
hypoxia impacts on these properties, and will speculate on impli-
cations of this work for hypoxia-induced organ dysfunction.
Hypoxia-induced modulation of vascular permeability
Increased vascular permeability is associated with hypoxemia,
and is especially evident in the setting of high altitude pulmonary
and cerebral edema [6, 7]. The barrier function of cultured
endothelial cells grown on nucleopore filters provides a model
system for analyzing mechanisms through which stimuli can
increase the transit of solutes across the endothelium, though
these monolayers are more permeable than the vessels from which
they were obtained [8—10]. Thus, studies in cell culture must have
parallels in intact animals in order for hypotheses formulated in
vitro to be meaningful. Nonetheless, this model system has been
used successfully to analyze means through which histamine,
thrombin and tumor necrosis factor (all agents which increase
permeability in vivo) affect endothelial barrier function.
Cultured pulmonary artery or aortic endothelial cells exposed
to hypoxia demonstrated increased diffusional transit of 3H-inulin
across the monolayers [12]. This occurred in a time-dependent
manner, and was most evident at low oxygen tensions (Fig. 1).
Morphologic studies showed that normoxic postconfluent endo-
thelial monolayers, initially having closely apposed cell-cell inter-
faces, developed occasional 1 to 3 micron gaps (Fig. 2). These
gaps provide a paracellular pathway through which leakage of
solutes could occur. Cyclic AMP (cAMP) levels in the endothe-
hum appeared to vary inversely with oxygen tension to which the
cultures were exposed and permeability; at lower P°2' cAMP
levels were reduced and diffusional transit of solutes was in-
creased. Since the cAMP content of epithelia is an important
determinant of its barrier function, we considered that hypoxia-
induced suppression of endothehial cAMP might he responsible
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for diminished barrier function. Several lines of evidence sup-
ported this concept: administration of membrane permeant
cAMP analogs, such as dibutyryl (db)-cAMP, prevented hypoxia-
mediated enhancement of permeability, whereas adenosine or
adenosine moriophosphate were without effect (Fig. 3). A stimu-
lator of type I protein kinase A (8-[4-ehlorophenylthio]adenosine
3',5'-phosphate) blocked the increase in permeability, as did a
stimulator of type II protein kinase A (N6-henzoyladenosine
3',5'-cyclic monophosphate). In the presence of both of these
agonists, hypoxia-induced hyperpermeability of endothclial
monolayers was suppressed to an even greater extent than with
either agent alone. Treatment of hypoxic endothelial cultures with
pertussis toxin prevented increased leakage of solutes and ele-
vated cAMP levels in the cells. The mechanism underlying
hypoxia-mediated suppression of cAMP was due to diminished
activity of adenylate cyclase. Basal, as well as forskolin- and
isoproterenol-stimulated adenylate cyclase activity, were sup-
pressed in hypoxic endothelial cells. In contrast, there was no
evidence for increased extrusion of cAMP into the culture me-
dium or a change in phosphodiesterase activity.
Suppression of cAMP in the endothelium following oxygen
deprivation would be expected to have effects on a range of
cellular homeostatic properties. For example, cAMP maintains
expression of the anticoagulant cofactor thrombomodulin and
suppresses induction of procoagulant tissue factor. cAMP also
suppresses expression of leukocyte adherence molecules, such as
E-selectin, and acts as a vasodilator through its effects on smooth
muscle cells. Thus, elevating cAMP in hypoxemic vaseulature
might have beneficial effects on vascular integrity by diminishing
activation of the procoagulant pathway, diminishing leukocyte
pooling in the tissue, and inducing vasodilation [12—14]. An ideal
setting in which to test this concept was that of organ preservation
for transplantation. The endothelium in transplanted organs is
well-known for its vulnerability to ischemia induced perturbations,
and this is a major limitation for the storage of organs, such as the
heart and lung. In fact, the requirement for a short preservation
time in heart and lung preservation limits the donor pool, imposes
logistical stress on both patient and physician, and prevents
laboratory studies which could allow improved donor/recipient
cross-matching.
These considerations led us to test the effect of adding mem-
brane permeant cAMP analogs to both the initial vascular flush
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Fig. 1. Hypoxia decreases endothelial barrier
function and intracellular cAMP levels.
Postconfluent endothelial monolayers were
exposed to hypoxia (P02 14 mm Hg) for 48
hours, and transfer of 3H-inulin across the
monolayer and cAMP content of the cells were
determined. Adapted from [II].
Fig. 2. Postconfluent cultured endothelial cells
display formation of intercellular gaps following
exposure to hypoxia (B) compared with norm oxic
controls (A).
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solution and organ baths in which hearts were preserved prior to
transplantation. A rat model of heterotopic cardiac transplanta-
tion was utilized [15], and preservation was carried out at 4°C, as
is used clinically. Addition of db-cAMP to the preservation
solution extended preservation in a time- and dose-dependent
manner (Fig. 4) [161. The experiment depicted in Figure 4 utilized
lactated-Ringers solution as the base preservative. To more
closely approximate the situation in clinical transplantation, the
current optimal clinical cardiac preservation solution (University
of Wisonsin solution, [17]) was utilized; the addition of increasing
amounts of membrane permeant cAMP analogs to the University
of Wisconsin solution similarly increased preservation time. The
effect of cAMP analogs on cardiac preservation required the
presence of cAMP or stimulation of the cAMP-dependent protein
kinase (protein kinase A), as was shown by several different lines
of experimentation. Another cAMP analog, 8-bromo-cAMP, had
a similar beneficial effect on cardiac preservation to db-cAMP,
whereas sodium butyrate or 8-bromoadenosine alone were inac-
tive. In fact, 8-bromo-cAMP, which penetrates membranes more
rapidly than db-cAMP, was more effective on a mole-to-mole
basis than db-cAMP. The protein kinase A stimulator Sp-cAMPS
mimicked dh-cAMP, whereas the antagonist isomer Rp-cAMPS
prevented the beneficial effect of 8-bromo-cAMP. Finally, addi-
tion of the specific phosphodiesterase inhibitors rolipram or
indolidan (given to reduce endogenous cAMP degradation) also
enhanced cardiac preservation.
Further studies were performed to determine mechanisms
through which buttressing the cAMP second messenger pathway
during cardiac preservation enhanced successful function of the
organ [161. Blood flow to the transplanted organ following release
of the cross-clamp was augmented in recipients of hearts pre-
served in the presence of cAMP. This was likely to be due to
several factors, including decreased vascular leakage, suppression
of intravascular clotting, and inhibition of leukocyte pooling. The
ability of cAMP to decrease leukocye accumulation in the trans-
planted heart was demonstrated by inspection of serial sections
and by diminished activity of the leukocyte marker enzyme
myeloperoxidase (Fig. 5). This is a potentially important finding,
as the presence of leukocytes correlates closely with tissue dam-
>
()
CU
0
A
** **
N=3 N=3 N=9 N=3 N=15N=1O N=5r,r,[ii.
—
U
Pr
r—ir-----iI
—
[1•
eservation
I I IL
—
—•
duration, hr
6
432
B
N=1 5
I I I
—
0 0.1 1 2 4
Dibutyryl cAMP concentration, m
65 l
4 .
3
2
I C)0
0
Fig. 4. Enhancedpreservation of rat hearts in the presence of db-cAMP: (A)
time course and (B) dependence on db-cAMP concentration. (A) Hearts
were explanted, flushed with cold lactated Ringer's solution solution alone
(D) or lactated Ringer's solution + db-cAMP (2 mM; •), and then stored
in the same solution at 4°C for the times indicated. Data are reported as
percent survival (left bar) or transplant score (right bar; transplant score
of 5 indicates optimum turgor, color, and contractility). (B). The experi-
ment was performed as in (A) except that the indicated concentration of
db-cAMP was used and the preservation time was held constant at 12
hours. Adapted from [16].
age. Our approach to augment second messenger systems sup-
pressed by hypoxia/preservation has been extended from rodent
models to a baboon orthotopic transplant model in which an
unprecedented 24-hour preservation period was successfully tol-
erated f19}. In addition, we have applied this technique to lung
preservation, a logical testing ground of our hypotheses, since the
0 0.5 1 0 0.1 0.5 1 0 0.1 0.5 1 0 0.1 0.5 1
L Normoxia Hypoxia—" Hypoxia
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db-cAMP, mM
Fig. 3. The membrane-permeant CAMP
analogue, dibutiyiyl (db)-cAMP suppresses
increased diffusional transit of 3H-inulin, 125j
albumin, or 3H-sorbitol across monolayers of
aortic (C]) or pulmonaty arterial () endothelium
exposed to hypoxia (PO2 14 mm Hg) for 48
hours. Adapted from [11].
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Fig. 5. Leukocyte accumulation in transplanted rat hearts. Hearts preserved for 12 hours with db-cAMP (A) showed no PMNs in a blood vessel (V),
whereas many adherent PMNs arc seen in the vessel from a graft preserved for 12 hours in lactated Ringer's solution alone (that is, no db-cAMP was
added; B). C. Leukocyte deposition was quantitated by assaying myeloperoxidase activity in the heart; failed grafts (stored in the absence of db-cAMP,
bar on left) demonstrate higher myeloperoxidase levels than those grafts stored in the presence of db-cAMP (bar on right). Analysis of leukocyte pooling
was made 10 minutes after blood flow to the transplanted heart was restored. Adapted from (161.
post-transplant lung is even more vulnerable to reperfusion injury
than the heart.
It has recently been reported that endothelial nitric oxide
synthase (eNOS) is suppressed by hypoxia [181. Thus, constitutive
nitric oxide production could be diminished by extended preser-
vation. Furthermore, generation of oxygen free radicals during the
early reperfusion period would quench any nitric oxide present.
This led us to perform further experiments using nitric oxide
donors, such as nitroprusside and nitroglycerin, cGMP analogs,
such as 8-bromo-cGMP, or the type V phosphodiesterase inhibi-
tor, zaprinast [20, 211. In each case, elevating cGMP in the organ
bath during preservation extended the time interval following
which successful transplantation could be achieved. Again, the
protective effect of cGMP analogs correlated closely with suppres-
sion of reperfusion injury. A solution combining agents which
augment both cAMP and cGMP has been suggested as a new
approach for improving the ability of transplanted organs to
maintain vascular homeostasis following re-establishment of
blood flow to the graft.
Hypoxia-mediated induction of interleukin-6
Many studies have addressed mechanisms underlying tissue
injury associated with ischemia, especially by evaluating cytotoxic
mechanisms during the reperfusion period. There are well-known
parallels between host response mechanisms activated in ischemia
and those invoked in inflammation. This led us to consider the
hypothesis that the period of hypoxia, prior to reperfusion, might
prime the subsequent vascular response by eliciting production of
proinflammatory cytokines. We oberved that mice subject to
hypoxia demonstrated increased levels of interleukin 1-alpha .Fig. 6. Immunostaining of hypoxic (B, D) and normoxic (A, C) mouse lung(IL-la) in the plasma [22]. This was likely to underlie the en- for interleukin-6. For hypoxia, mice were expsed to 6% oxygen for six hours
hanced expression of intercellular adhesion molecule (TCAM)-1 in a specially controlled environmental chamber. Adapted from [251.
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in hypoxic lung compared with normoxic controls [221. Further-
more, endothelial synthesis of the chemokine IL-8, which stimu-
lates leukocyte chemotaxis, binding and activation, was also
enhanced in hypoxia and, thus, could promote leukostasis in
hypoxic organs [23, 24]. This was consistent with increased
myeloperoxidase activity, a marker enzyme for polymorphonu-
clear leukocytes, in lungs of hypoxic compared with normoxic
mice, as well as in samples of blood obtained directly from the
coronaty sinus of human hearts preserved for prolonged periods
[24].
Although these studies provided support for the concept that
hypoxia was associated with induction of pro-inflammatory medi-
ators, it was apparent from the pathologic picture that the host
response to these cytokines was suppressed. This led us to
speculate that other substances, potentially with anti-inflamma-
tory properties, were also being produced, and, thereby, were
modulating the tissue response. Our initial studies focused on
lL-6, as this cytokine when administerd acutely in vivo or in vitro
has anti-inflammatory effects. For example, IL-6 suppresses IL-i
and tumor necrosis factor (TNF) production by stimulated mac-
rophages and causes increased expression of soluble TNF and
IL-I receptors. Endothelial cells subjected to hypoxia demon-
strated increased production of IL-6 antigen that was preceded by
induction of IL-6 transcripts [251. Hypoxia-induced expression of
IL-6 was driven by an increase in the rate of transcription (about
8- to 11-fold) as shown by nuclear run-on analysis. Studies in lung
from hypoxic mice also showed expression of IL-6 in the vascu-
lature (Fig. 6); staining is evident in endothelium and smooth
muscle cells.
To assess mechanisms underlying enhanced expression of IL-6
in hypoxic endothelium, transient transfection studies were per-
formed using a series of deletional IL-6 promoter-reporter gene
constructs (Fig. 7). Hypoxia-mediated enhancement of reporter
gene expression was lost when the region — 225!—111 was deleted.
Furthermore, experiments in which this 115 bp fragment was
placed in the 5'-to-3' or 3'-to-5' orientation and linked to the
basal thymidine kinase promoter and to a chloramphenicol acetyl—
transferase (CAT) reporter demonstrated properties of an en-
hancer. Parallel electrophoretic mobility gel shift assays using
tt_ z I U)U- ,-;-U.. (I) ...
('J Z(.'J 0I o ++ I8i +
+ II
Fig. 8. Binding of endothelial nuclear extracts to the IL-6 promoter (—225!
—Ill) by electrophoretic mobility gel shift assay. Endothelial cells were
exposed to hypoxia (H; P°2 14 mm Hg for 4 hr) or normoxia in
serum-free medium (N) or normoxia in the presence of fetal calf serum
(S). FP indicates free probe, and cold indicates that a 100-fold molar
excess of the indicated unlabeled probe was added to assess specificity of
binding. Adapted from [251.
+13 CAT
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I -
—1180
plCl200
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plC225
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pTKC1225/1 11
pTKCi1 11/225
pTKC
pCAT-basic
pCAT-control
\ Fig. 7. Transient transfection of IL-6 promoter-\ \\\X\\\\\\\\\\\\\\\\\\\\\X\\\\\X\
—.
reporter (CAT, chloramphenicol acetyltransferase)
_________________________
constructs into endothelial cells. The constructs
employed contained the following portions of
the IL-6 promoter: —12001+13, pICl200; —596/
+13, pIC596; —225/+13, pIC225; —111/+10,
p1db; —225/—ill ligated to the basal
kinase promoter in the 5'-to-3' or
3'-to-5' orientation, pTKCi225/i11 or
0 2 4 6 8 10 12 pTKCi1I1I225, respectively. Symbols are: ()
serum; (•) hypoxia; (111) normoxia. AdaptedRelative cat activity from [25].
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—225/—ill as the labeled oligonucleotide probe showed a strong
enhancement of the hand in nuclear extracts from hypoxic endo-
thelial cells (Fig. 8). Binding was specific, as it was blocked by
excess unlabeled —225/—ill oligonucleotide probe, hut not oh-
gonucleotides for Spl or hypoxia-inducible factor (HIF)-i DNA
binding motifs [26]. As there are multiple potential regulatory
sites in —225/—Ill, a series of overlapping oligonucleotidcs was
made and tested as unlabeled competitors. Only unlabeled 14 bp
oligonucleotide corresponding to the NF-IL-6 site (—158/—145)
reduced intensity of the gel shift band in nuclear extracts from
hypoxic endothehia to levels observed in normoxia. Further gel
shift analysis was performed using the NF-IL-6 oligonucleotide
and demonstrated a striking induction of binding activation in
nuclear extracts from hypoxic cultured endothelial cells and lung
harvested from hypoxic mice. These data were consistent with the
results of transient transfection studies using constructs consisting
of the NF-IL-6 DNA binding motif ligated to the basal thymidine
kinase promoter and a reporter (CAT). Transfection of endothe-
hal cells with this construct resulted in selective expression in
hypoxia. Similar constructs in which the NF-IL-6 site was muta-
tionally inactivated displayed no expression of the reporter.
These findings demonstrate that hypoxia induces endothelial
expression of IL-6. Activation of transcription is driven by the
NF-IL-6 DNA binding site in the IL-6 promoter. Further studies
are underway to determine if increased production of IL-6 has a
protective effect in models of ischemia, and to assess mechanisms
underlying hypoxia-mediated induction of DNA binding activity
for NF-IL-6 sites.
Conclusions
The study of cultured endothelial cells exposed to hypoxia can
may regulate transcription of a number of genes when endothe-
hum or other cells are exposed to an environment with limiting
oxygen. We hypothesize that hypoxia-mediated expression of IL-6
may have protective effects for the vasculature in isehemia.
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